Last reviewed · How we verify
Epirenamine (racepinefrine)
Epirenamine (generic name: racepinefrine) is a racepinefrine drug. It is currently FDA-approved.
Epirenamine is a small molecule medication that is the racemic form of epinephrine, also known as adrenaline. It is used as a vasoconstrictor, bronchodilator, cardiostimulant, mydriatic, and antiglaucoma agent, typically in its hydrochloride salt form.
At a glance
| Generic name | racepinefrine |
|---|---|
| Drug class | racepinefrine |
| Target | Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epirenamine CI brief — competitive landscape report
- Epirenamine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Epirenamine
What is Epirenamine?
Epirenamine (racepinefrine) is a racepinefrine drug.
What is the generic name of Epirenamine?
racepinefrine is the generic (nonproprietary) name of Epirenamine.
What drug class is Epirenamine in?
Epirenamine belongs to the racepinefrine class. See all racepinefrine drugs at /class/racepinefrine.
What development phase is Epirenamine in?
Epirenamine is FDA-approved (marketed).
What does Epirenamine target?
Epirenamine targets Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor and is a racepinefrine.
Related
- Drug class: All racepinefrine drugs
- Target: All drugs targeting Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing